Hyperlipoproteinemia, Type IIa clinical trials
16 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
- Multicomponent Intervention Study- Blood Donors With High Cholesterol
- Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
- Comparing Direct vs Indirect Methods for Cascade Screening
- The ORIGIN-FH Study
- Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Atlantic Lipid Lowering Treatment Optimization Program
- Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP
- Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
- Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
- Penn Family Screening for Familial Hypercholesterolemia
- Improving Diagnosis and Clinical Management of Familial Hypercholesterolemia Through Integrated Machine Learning, Implementation Science, and Behavioral Economics
- Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
- Improving Lipid Optimization Quality and Treatment Options in ASCVD
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hyperlipoproteinemia, Type IIa” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.